Cryopreserved products have been used in drug research not only by Celsis IVT but also by other leading scientists and academicians for more than a decade. In 2006, the U.S. Food and Drug Administration (FDA) drafted Guidance for Industry advising that cryopreserved tools are a viable and acceptable alternative to fresh research products. Drug Interaction Studies - Study Design, Data Analysis, and Implications for Dosing and Labeling (draft): Guidance for Industry, FDA, September 2006. The following posters include information regarding the use of cryopreservation products in ADME-Tox research. Additional Celsis IVT posters are available in our Resource Center. Poster: Effects of Cryopreservation on P450 Oxidation and Phase II Conjugation Activity Poster: A High Throughput Screening Assay for Hepatotoxicity Using Cryopreserved Poster: Comparison of Fresh and Cryo Cyno Monkey Hepatocyte CYP P450 Levels For more information, please contact Celsis IVT. |
|
